Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors

por | Ene 1, 2022 | Publicaciones - CIMO-01 | 0 Comentarios

Girard, N; Minchom, A; Ou, SHI; Gadgeel, SM; Trigo, J; Viteri, S; Bauml, JM; Londhe, A; Mahadevia, P; Bazhenova, L – 2022